In vivo Reduction of Amyloid-β by a Mutant Copper Transporter

Cu ions have been suggested to enhance the assembly and pathogenic potential of the Alzheimer's disease$amyloid\!-\!\beta\>(A\beta)$peptide. To explore this relationship in vivo, toxic-milk (txJ) mice with a mutant ATPase7b transporter favoring elevated Cu levels were analyzed in combination...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS Vol. 100; no. 24; pp. 14193 - 14198
Main Authors: Phinney, Amie L., Drisaldi, Bettina, Schmidt, Stephen D., Lugowski, Stan, Coronado, Veronica, Liang, Yan, Horne, Patrick, Yang, Jing, Sekoulidis, Joannis, Coomaraswamy, Janaky, Chishti, M. Azhar, Cox, Diane W., Mathews, Paul M., Nixon, Ralph A., Carlson, George A., St George-Hyslop, Peter, Westaway, David
Format: Journal Article
Language:English
Published: United States National Academy of Sciences 25-11-2003
National Acad Sciences
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cu ions have been suggested to enhance the assembly and pathogenic potential of the Alzheimer's disease$amyloid\!-\!\beta\>(A\beta)$peptide. To explore this relationship in vivo, toxic-milk (txJ) mice with a mutant ATPase7b transporter favoring elevated Cu levels were analyzed in combination with the transgenic (Tg) CRND8 amyloid precursor protein mice exhibiting robust Aβ deposition. Unexpectedly, TgCRND8 mice homozygous for the recessive txJmutation examined at 6 months of age exhibited a reduced number of amyloid plaques and diminished plasma Aβ levels. In addition, homozygosity for txJincreased survival of young TgCRND8 mice and lowered endogenous CNS Aβ at times before detectable increases in Cu in the CNS. These data suggest that the beneficial effect of the txJmutation on CNS Aβ burden may proceed by a previously undescribed mechanism, likely involving increased clearance of peripheral pools of Aβ peptide.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Edited by Thomas C. Südhof, University of Texas Southwestern Medical Center, Dallas, TX, and approved September 16, 2003
This paper was submitted directly (Track II) to the PNAS office.
To whom correspondence should be addressed at: Center for Research in Neurodegenerative Diseases, University of Toronto, 6 Queen's Park Crescent West, Toronto, ON, Canada M5H 3S2. E-mail: david.westaway@utoronto.ca.
Abbreviations: Aβ, amyloid-β; AD, Alzheimer's disease; APP, amyloid precursor protein; sAPP, secreted APP fragments; CSF, cerebrospinal fluid; LSD, least significant difference; Tg, transgenic.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.2332851100